Canadian pharmaceutical company Apotex announced the appointment of Dr. Jeremy Desai to president and CEO. He has spent close to 30 years in a number of senior roles within the pharmaceutical industry and has been with Apotex for the last 11 years.
Mylan on Wednesday announced that U.S. District Court for the district of New Jersey granted a temporary restraining order against Apotex Inc. and Apotex Corp. relating to Paroxetine CR.
A federal court has ruled that a Mylan lawsuit against GlaxoSmithKline over an antidepressant drug can go to trial.
The Generic Pharmaceutical Association re-elected its chairman from last year and appointed a new board of directors for 2013 whose members run from A to Z — as in Amneal to Zydus.
Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.
The Food and Drug Administration has approved two generic versions of a drug to treat HIV, according to agency records.
Ranbaxy Labs has launched an authorized generic drug for treating dry mouth associated with an autoimmune disorder, the company said Tuesday.
A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.
The Food and Drug Administration has approved the first generic version of a drug for treating and preventing osteoporosis in women after menopause, the agency said Monday.
GlaxoSmithKline can sell an authorized generic of its antidepressant drug to Toronto-based drug maker Apotex, a U.S. judge ruled.
A U.S. District Court denied a motion for a preliminary injunction filed by Mylan to...
A U.S. District Court has blocked Canadian generic drug maker Apotex from selling generic versions...